We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B Turnover 22.5%
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+13.79%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.82B
AUM Growth
+$522M
Cap. Flow
+$73.4M
Cap. Flow %
1.52%
Top 10 Hldgs %
20.44%
Holding
604
New
109
Increased
179
Reduced
173
Closed
43
Avg Time Held
0.2 years
Top 10 Avg Time Held
0.1 years
Top 20 Avg Time Held
0.2 years

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$48.8M
2
CMCSA icon
Comcast
CMCSA
+$46.9M
3
AVY icon
Avery Dennison
AVY
+$38.5M
4
MIDD icon
Middleby
MIDD
+$33M
5
LKQ icon
LKQ Corp
LKQ
+$32.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.65%
2 Financials 14.81%
3 Industrials 14.31%
4 Technology 11.57%
5 Energy 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BMY icon
201
Bristol-Myers Squibb
BMY
$124B
$1.33M 0.03%
28,674
+2,251
+9% +$98.8K
2013 Q2
1 quarter
SLV icon
202
iShares Silver Trust
SLV
$27.9B
$1.31M 0.03%
62,511
-3,560
-5% -$73.5K
2013 Q2
1 quarter
DE icon
203
Deere & Co
DE
$175B
$1.27M 0.03%
15,595
+10,565
+210% +$880K
2013 Q2
1 quarter
WEC icon
204
WEC Energy
WEC
$34.6B
$1.25M 0.03%
31,078
– –
2013 Q2
1 quarter
KMP
205
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$1.25M 0.03%
15,632
-3,767
-19% -$312K
2013 Q2
1 quarter
LOPE icon
206
Grand Canyon Education
LOPE
$4.21B
$1.23M 0.03%
30,565
+9,875
+48% +$352K
2013 Q2
1 quarter
FDX icon
207
FedEx
FDX
$69.9B
$1.23M 0.03%
10,755
– –
2013 Q2
1 quarter
DIS icon
208
Walt Disney
DIS
$191B
$1.22M 0.03%
18,833
-845
-4% -$54.2K
2013 Q2
1 quarter
COV
209
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$1.22M 0.03%
19,940
-11,480
-37% -$700K
2013 Q2
1 quarter
EFA icon
210
iShares MSCI EAFE ETF
EFA
$76.9B
$1.2M 0.02%
18,784
-1,193
-6% -$73.1K
2013 Q2
1 quarter
RRC icon
211
Range Resources
RRC
$9.68B
$1.2M 0.02%
15,770
-5,080
-24% -$397K
2013 Q2
1 quarter
VALE icon
212
Vale
VALE
$55.4B
$1.19M 0.02%
+76,140
New +$1.13M
2013 Q3
0 quarters
VWO icon
213
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$1.19M 0.02%
29,563
+1,135
+4% +$44.9K
2013 Q2
1 quarter
TW icon
214
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$1.18M 0.02%
+11,070
New +$974K
2013 Q3
0 quarters
CMCSK
215
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$1.18M 0.02%
27,105
+63
+0.2% +$2.73K
2013 Q2
1 quarter
NSC icon
216
Norfolk Southern
NSC
$73B
$1.16M 0.02%
14,927
-732
-5% -$54.8K
2013 Q2
1 quarter
TEVA icon
217
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
$1.15M 0.02%
30,432
+14,289
+89% +$557K
2013 Q2
1 quarter
IJR icon
218
iShares Core S&P Small-Cap ETF
IJR
$103B
$1.15M 0.02%
23,030
-340
-1% -$16.4K
2013 Q2
1 quarter
YUM icon
219
Yum! Brands
YUM
$41.2B
$1.1M 0.02%
21,396
-1,836
-8% -$95.2K
2013 Q2
1 quarter
MDLZ icon
220
Mondelez International
MDLZ
$80.4B
$1.09M 0.02%
34,725
-364
-1% -$11.3K
2013 Q2
1 quarter
BKNG icon
221
Booking.com
BKNG
$125B
$1.08M 0.02%
+26,775
New +$1M
2013 Q3
0 quarters
IWB icon
222
iShares Russell 1000 ETF
IWB
$49.2B
$1.06M 0.02%
11,263
+77
+0.7% +$7.2K
2013 Q2
1 quarter
TREX icon
223
Trex
TREX
$4.71B
$1.05M 0.02%
169,960
+26,920
+19% +$157K
2013 Q2
1 quarter
CTU.CL
224
DELISTED
Qwest Corporation
CTU.CL
$1.04M 0.02%
43,250
+750
+2% +$18.5K
2013 Q2
1 quarter
ABT icon
225
Abbott
ABT
$181B
$1.03M 0.02%
31,168
-2,921
-9% -$102K
2013 Q2
1 quarter

Similar funds

Geneva Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Geneva Advisors held 604 positions worth $4.82B, up 12% from $4.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneva Advisors's Q3 2013 filing shows 109 new, 179 increased, 173 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M. The largest sale was Monsanto Co, an estimated $63.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q3 2013 buy was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M.
  • Geneva Advisors added most to Comcast in Q3 2013, an estimated $46.9M increase.
  • Geneva Advisors's biggest Q3 2013 reduction was Monsanto Co, cutting an estimated $63.1M.
  • Geneva Advisors fully exited Valmont Industries in Q3 2013, selling an estimated $36.7M.
  • Geneva Advisors's ten largest holdings make up 20% of its $4.82B portfolio in Q3 2013.
  • Geneva Advisors opened 109 new positions and closed 43 in Q3 2013.
  • Geneva Advisors's portfolio value rose 12% quarter-over-quarter to $4.82B.

Based on Geneva Advisors's 13F filing for Q3 2013, filed 4 Nov 2013.